Gene · 115650
Papers2,634
Newest first. Swiss-Prot's references are curated; PubTator's text mining finds papers that name the gene, not always ones about it.
1 to 20 of 2,634
Download this page as JSON| Title | Journal | Year | PMID | Found by | Source |
|---|---|---|---|---|---|
| Shared Genetic Basis of Autoimmune Diseases and Follicular Lymphoma by Mendelian Randomization and Multi-Omics. | Genes (Basel) | 2026 | 42792925 | PubTator, text mining | PubMed |
| BAFF and APRIL Receptors in B Cell Immunity and Autoimmunity. | Immunol Rev | 2026 | 42755123 | PubTator, text mining | PubMed |
| Stratifying lung adenocarcinoma: a novel prognostic model based on mitochondrial outer membrane permeabilization activity. | 3 Biotech | 2026 | 42745950 | PubTator, text mining | PubMed |
| Evolving Paradigms in the Management of Primary Immune Thrombocytopenia in Adults: From Corticosteroids to Targeted Therapies. | Mediterr J Hematol Infect Dis | 2026 | 42730410 | PubTator, text mining | PubMed |
| Previous malaria exposure attenuates monocyte-driven inflammation and correlates with modulation of the B cell response. | JCI Insight | 2026 | 42709494 | PubTator, text mining | PubMed |
| The BAFF-BAFF-R axis in systemic sclerosis: a reciprocal signature of active B-cell dysregulation. | Rheumatology (Oxford) | 2026 | 42693937 | PubTator, text mining | PubMed |
| B-cell depletion therapy in systemic lupus erythematosus: emerging strategies and challenges. | Expert Opin Biol Ther | 2026 | 42663595 | PubTator, text mining | PubMed |
| Targeting B-Cell-Activating Factor and Its Receptor in Immune Thrombocytopenia and Warm Autoimmune Hemolytic Anemia. | Am J Hematol | 2026 | 42661578 | PubTator, text mining | PubMed |
| Bridging the Gap in Sjögren's Disease: A Comprehensive Review of Unmet Needs, Diagnostic Challenges, and Emerging Therapeutic Strategies. | Cureus | 2026 | 42633339 | PubTator, text mining | PubMed |
| BAFF-R CAR T-cell therapy for relapsed or refractory B-cell lymphomas. | Lancet | 2026 | 42624808 | PubTator, text mining | PubMed |
| BAFF and APRIL signaling in the B-cell lineage: implications for the pathogenesis of ANCA-associated vasculitis. | Front Immunol | 2026 | 42553115 | PubTator, text mining | PubMed |
| Polymorphonuclear Myeloid-Derived Suppressor Cells Promote Rheumatoid Arthritis by Inducing Age-Associated B Cells Proliferation and Differentiation via the BAFF-Mediated SYK-ERK1/2 Pathway. | FASEB J | 2026 | 42508033 | PubTator, text mining | PubMed |
| B-cell activating factor receptor expression in B-lymphoblastic leukaemia: Flow cytometric analysis and implications for targeted therapy. | Br J Haematol | 2026 | 42496076 | PubTator, text mining | PubMed |
| Balancing Act: The Dual Roles of BAFF in Systemic Lupus Erythematosus. | Drugs | 2026 | 42479350 | PubTator, text mining | PubMed |
| Human single domain antibody-based CAR-T cells targeting BAFF-R demonstrate promising preclinical activity in B-cell malignancies. | BMC Cancer | 2026 | 42387444 | PubTator, text mining | PubMed |
| Disease activity and anti-topoisomerase I antibody positivity are associated with elevated serum B cell activating factor levels and a B cell subset-wide reduction of BAFF-receptor expression in SSc. | Rheumatology (Oxford) | 2026 | 42384965 | PubTator, text mining | PubMed |
| Cerebrospinal Fluid Transcriptional Immune Pathways Linked to Survival in HIV-Associated Tuberculous Meningitis. | J Infect Dis | 2026 | 42313402 | PubTator, text mining | PubMed |
| Exploring causality between peripheral blood B cell subtypes and membranous nephropathy: a two-sample Mendelian randomization study. | Arch Med Sci | 2026 | 42305334 | PubTator, text mining | PubMed |
| Stage-resolved mapping of RP105 (CD180)-negative B cells reveals residual plasmablast-lineage skewing in SLE: a cross-sectional study. | Lupus Sci Med | 2026 | 42303414 | PubTator, text mining | PubMed |
| Environmental Pollutant Tetrachloro-1,4-benzoquinone Exerts Neurotoxicity and Potential Protective Effects of Curcumin: A Network and Mendelian Randomization Analysis. | Curr Top Med Chem | 2026 | 42283184 | PubTator, text mining | PubMed |
gene-search-2026-11-11-0.2.0
Sources 12
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- EMBL-EBI's patent proteinsNo added restrictions. Attribution expected
- GenBank's patent filesNo restrictions from NCBI. Submitters may hold rights
- HGNCCC0
- NCBI GenePublic domain (US government)
- NIH's project files and grant-paper linksPublic domain
- Open TargetsCC0 1.0
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- EMBL-EBI's patent proteinsEMBL-EBI's patent protein files from the EPO, JPO, KIPO and USPTO. EMBL-EBI: "EMBL-EBI itself places no additional restrictions on the use or redistribution of the data available via its Data Resources and Tools other than those provided by the original data owners" and "EMBL-EBI expects attribution (e.g. in publications, services or products) for the use of any of its Data Resources and Tools." Read on 11 Nov 2026 at https://www.ebi.ac.uk/about/terms-of-use
- GenBank's patent filesGenBank's patent files. NCBI: "NCBI places no restrictions on the use or distribution of the GenBank data. However, some submitters may claim patent, copyright, or other intellectual property rights in all or a portion of the data they have submitted." Read on 11 Nov 2026 at https://www.ncbi.nlm.nih.gov/genbank/about/
- HGNCCC0: https://www.genenames.org/about/license/
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH's project files and grant-paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this list from software.
Twenty rows a page, as JSON. No key.
GET https://conductscience.org/api/genes/v1/115650/papers